Technology Update: SAPIEN Heart Valve Replacement Trial Impresses Many (Part I)
Wednesday, September 29th, 2010In case you missed it… Last week, The New England Journal of Medicine published results from the PARTNER Trial, a unique study that examines the safety and efficacy of the new, transcatheter SAPIEN heart valve replacement. Manufactured by Edwards Lifesciences, this investigational device is designed to treat aortic stenosis by replacing the patient’s aortic valve through a catheter — without causing any trauma to the patient’s sternum or ribs.

Edwards Sapien Heart Valve Replacement
Needless to say, the medical community, the investment community and our patient community have been anxiously awaiting results of this study for the SAPIEN device — which has yet to receive FDA approval in the United States.


















